1. Substances proposed for evaluation at the 47th meeting of JECFA in June 1996
Abamectin (residues)*
Ceftiofur sodium (residues)*
Chlortetracycline (residues)*
Oxytetracycline (residues)*
Tetracycline (residues)*
Clenbuterol
Cypermethrin a-Cypermethrin
Neomycin (toxicology)*
Porcine somatotropin
Spectinomycin (residues)*
Spiramycin (residues)*
Thiamphenicol
Tilmicosin
Xylazine
2. Substances provisionally proposed for evaluation at the 48th meeting of JECFA in February 1997
Cyfluthrin
Danofloxacin
Dexamethasone (methodology)*
Dihydrostreptomycin*
Streptomycin*
Enrofloxacin*
Fluazuron
Flumequine*
Gentamicin*
Imidocarb
Thiabendazole (toxicology)*
3. Substances provisionally proposed for evaluation at the 50th meeting of JECFA in February 1998
Azaperone*
Diclazuril*
Febantel*
Fenbendazole*
Oxfendazole*
Metrifonate
Moxidectin*
Olaquindox (residues)*
* reevaluation.
Note: Of all the substances on the CCRVDF Priority List, only nicarbazin is not scheduled for review by JECFA. The timing of the review depends on the availability of relevant data.